SCHULTZ-FADEMRECHT, CARSTEN C-,.舒爾茨-法德姆雷希特,KLEBL, BERT B,.克勒布爾,CHOIDAS, AXEL A,.霍伊達斯,KOCH, UWE U,.科赫,EICKHOFF, JAN J,.艾克霍夫,WOLF, ALEXANDER A,.沃爾夫,ULLRICH, AXEL A,.烏爾裡希
申请号：
HK13113372.6
公开号：
HK1185879B
申请日:
2013.11.29
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
The present invention relates to 1-nitrogen-heterocyclic-2-carboxamides of general formula (I): and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the treatment and/or prevention of Axl receptor tyrosine kinase subfamily induced disorders, including cancer and primary tumor metastases, and pharmaceutical compositions containing at least one of said 1-nitrogen-heterocyclic-2-carboxamide derivatives and/or pharmaceutically acceptable salts thereof.
